ESR1 and neoplasm: As seven of the nine [18F]FES-negative patients showed a positive [18F]FDG uptake, the false-negative results cannot be explained by the limited spatial resolution of PET/CT, but rather reflect the low ER expression levels in tumor, or inherent differences between ER assays and [18F]FES uptake [31, 39].